SUMMER WATCH LIST

Verisante Technology has been the right company in the right space. Now is it the right time? Some feel its about to have a bounce as the CEO puts together a plan for sales. Everyone is anxious to see the first units delivered to dermatologists around the globe. The beauty of the Verisante Aura is anyone with some training can operate it. Its set up for quick and easy operation. The company has a lot of cash push production and once institutional investors take a more active position this will be the market darling once more.

Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and the University of British Columbia and tested and refined on approximately 1,000 lesions at the Skin Care Centre at Vancouver General Hospital. http://www.verisante.com/

Miraculins focuses on in-licensing/acquiring and developing both cancer and non-cancer diagnostic opportunities that have completed early stage research and address unmet clinical needs.

Miraculins’ internal research program has lead to the discovery and identification of prostate cancer biomarkers, the lead marker of which is called Prostate Secretory Protein or PSP94. Miraculins also acquired several biomarkers in the areas of Gastric, Colorectal, and Pancreatic Cancer and are in the process of moving those programs further through the pipeline.

With the experience gained from developing its first assay, and the addition of a strong scientific team, Miraculins has developed a process and criteria for evaluating technologies as potential licensing targets.

Once Miraculins has determined that a specific technology meets its criteria the Company adds value to the early stage research by developing a clinical grade assay, confirming the diagnostic potential of the technology and moving the test through to regulatory approval and commercial sales.  http://www.thenextbiggestwinner.com/miraculins/#.T4mb3NV0S8B

 

Chemaphor Inc. operates in the multi-billion dollar animal and human health markets. The company’s goal is to commercialize a range of product applications from its technology platforms with:

• secured licensing agreements
• collaborations and alliances with selected industry partners
• the successful launch of pet products in the US and Canada
• the strengthening of an already sound IP portfolio

Chemaphor's technologies are based on Natural Health Optimizers ("NHOs"). NHOs work with and support the natural systems that exist within the body to strive to maintain optimal health and function, e,g, by supporting immune function. Chemaphor’s major technology is Fully Oxidized Beta-Carotene (OxC-beta). http://www.chemaphor.com/pdf/CFR%20Investor%20Presentation%20Feb%202012.pdf

 

 Mahdia Gold Corp has officially acquired the renowned Omai gold property. The Omai concession covers highly valuable ground and is divided into different pits: the Fennell pit, the Wenot pit and possible additional deposits according to reports and data collected. Mahdia Gold gets its name from a popular resource rich mining town located in central Guyana. Historically the central Guyanese region was made popular by the Omai gold mine. This mine produced approximately 4.000.000 ounces of gold from two open pits. Having identified the potential of this region, Mahdia Gold Corp. has acquired three compelling gold bearing concessions, namely, Omai, Tiger River and White Creek. The company's vision is to be an aggregator of world class gold properties in the country of Guyana. This vision includes maximizing shareholder value and Mahdia Gold Corp. being the premier destination for investors looking to invest in the precious commodity known as gold. http://www.mahdiagold.com/

 

Asantae has attracted thousands of Affiliates who not only use our products, but are building successful businesses with our unrivaled formula for greater health and wealth. We are continuing to take our mission worldwide as we expand internationally to other markets and are poised for unprecedented growth. Asantae RealW8™ is the first weight-loss supplement to address the main catalyst of weight gain and excess fat storage, which is our craving for and overindulgence of carbohydrates and sugar. The real problem is controlling the spikes in blood sugar that occur after we eat the typical American diet. These spikes make us unable to resist the sugar and carbohydrates that big food brands bombard us with constantly. RealW8 is a proprietary blend of natural ingredients scientifically engineered to help you control those carbohydrate and sugar cravings that cause you to gain weight and be unhealthy.  http://www.asantae.com/Web/ww/en/products-why-realw8.dhtml

 

CONTENT POSTED ON THIS BLOG DOES NOT CONSTITUTE A BUY OR SELL RECOMMENDATION. MANY OF THE COMPANIES PROFILED HERE I AM NOT INVESTED IN AND DO NOT INTEND TO INVEST IN. THESE ARE MERELY MY THOUGHTS ON MARKET CONDITIONS AND STOCK VALUATIONS. INVESTING IN THE STOCK MARKET CAN BE VERY RISKY AND YOU SHOULD ALWAYS CONSULT AN INVESTMENT PROFESSIONAL BEFORE MAKING ANY DECISIONS. ULTIMATELY YOU ARE RESPONSIBLE FOR CONDUCTING YOUR OWN DUE DILIGENCE AND PROTECTING YOUR MONEY.